Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
William Tamborlane
Yale University, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Patton Medical Devices
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Please see the attached document for the required information.
Diabetes Mellitus and Disorders of Metabolism
Obesity, diabetes and osteoporosis represent a spectrum of increasingly prevalent metabolic diseases that are responsible for a great burden of suffering and death in the US and throughout the world. Academic endocrine researchers are needed to better understand these disorders and to translate research findings into new therapies. Our training program in diabetes and disorders of metabolism is dedicated to providing young physicians and scientists with the research training necessary to tackle these important health problems.
Filed on July 01, 2014.
Tell us what you know about William Tamborlane's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
William Tamborlane filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| William Tamborlane | Yale University | Conflict of Interest | Insuline Medical, Ltd. | $60,000 - $79,999 |
| William Tamborlane | Yale University | Conflict of Interest | Insuline Medical, Ltd. | $40,000 - $59,999 |
| William Tamborlane | Yale University | Conflict of Interest | Novo Nordisk Pharmaceuticals | $20,000 - $39,999 |
| William Tamborlane | Yale University | Conflict of Interest | Medtronic Diabetes | $20,000 - $39,999 |
| William Tamborlane | Yale University | Conflict of Interest | Grove Instruments | $20,000 - $39,999 |
| William Tamborlane | Yale University | Conflict of Interest | Bristol-Myers Squibb | $20,000 - $39,999 |
| William Tamborlane | Yale University | Conflict of Interest | Takeda Pharmaceuticals | $10,000 - $19,999 |
| William Tamborlane | Yale University | Conflict of Interest | Sanofi US | $10,000 - $19,999 |
| William Tamborlane | Yale University | Conflict of Interest | Boehringer-Ingelheim | $10,000 - $19,999 |
| William Tamborlane | Yale University | Conflict of Interest | Thermalin | $5,000 - $9,999 |
| William Tamborlane | Yale University | Conflict of Interest | Thermalin | Value cannot be readily determined |
| William Tamborlane | Yale University | Conflict of Interest | Grove Instruments | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.